ERBB2 and breast carcinoma: The latter being less prone to be treated Over St Gallen if suffering luminal A-like and more prone to be treated Under St Gallen if suffering any other intrinsic breast cancer subtype (luminal B-like, Her2 non-luminal or triple negative), meaning that in all subtypes, women over 65 received less treatment on average.